RecruitingNot ApplicableNCT05977751

Prospective Multi-Center Trial for FemBloc Permanent Birth Control

FINALE: Prospective Multi-Center Trial for FemBloc INtratubal Occlusion for TranscervicAL PErmanent Birth Control

Sponsor

Femasys Inc.

Enrollment

573 participants

Start Date

Oct 31, 2023

Study Type

INTERVENTIONAL

Conditions

Contraception

Summary

Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.

Eligibility

Sex: FEMALEMin Age: 21 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called FemBloc for people with contraception. The study is currently recruiting participants at 8 locations. People eligible for this study include women aged 21 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFemBloc

Treatment for women who desire non-surgical permanent birth control by occlusion of the fallopian tubes.

Locations(10)

New Horizons Clinical Trials

Chandler, Arizona, United States

Stanford University

Palo Alto, California, United States

University of California Davis

Sacramento, California, United States

Midtown OB GYN North

Columbus, Georgia, United States

Rosemark WomenCare Specialists

Idaho Falls, Idaho, United States

Maimonides Medical Center

Brooklyn, New York, United States

Columbia University Medical Center

New York, New York, United States

Seven Hills Women's Health Centers

Cincinnati, Ohio, United States

Chattanooga Medical Research LLC

Chattanooga, Tennessee, United States

University of Utah

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05977751

Related Trials

Etonogestrel Implant as Emergency Contraception

NCT052371411 location

Long Term Evaluation of Scapular-inserted Contraceptive Implants

NCT072014022 locations

Trial of the "Mittin" Intervention to Improve Contraceptive Side Effect Counseling and Follow-up in Ethiopia

NCT073012811 location

"Vasectomy: Right for Me?" Decision Support Tool

NCT074510672 locations

Oral Contraceptive Pill (OCP) Pharmacogenomics

NCT063343152 locations